StockData
Larimar Therapeutics, Inc. logo

Larimar Therapeutics, Inc. (LRMR) bonds

LRMRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 5/30
$3.00−0.02 (-0.66%)

Close on Nov 16, 2026Market cap $311.65MP/E –Yield –

Debt

Borrowings on the balance sheet, Jun 30, 2026

Larimar Therapeutics reports no long-term debt line

Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.

When the debt comes due

Principal repayments of long-term debt by fiscal year, as scheduled at Dec 31, 2019

From the debt maturity table in the annual report (filing). “Later” is everything due after year five.

Notes and loans outstanding

Individual notes, bonds and loans

Larimar Therapeutics's filings do not break debt down by note

The debt footnote in the annual report has no machine-readable detail for individual notes, so coupons and maturities cannot be listed. The repayment schedule above comes from the same report.

See a number that looks wrong?